Head-to-head clinical analysis & difference comparison: details on mechanism of action, dosing, half-life, interactions, and maternal-fetal safety.
PHYSIOLYTE IN PLASTIC CONTAINER vs PUR-WASH
Clinician-reviewed, head-to-head comparison of mechanism, dosing, pharmacokinetics, and safety profiles.
Last clinically reviewed: July 2026 · OpiCalc Medical Review Team
Physiolyte is an isotonic crystalloid solution that provides electrolytes and water to maintain or restore intravascular volume and correct fluid and electrolyte imbalances. The mechanism involves distribution of fluids between intravascular and interstitial spaces, with electrolytes contributing to osmotic balance and physiological functions.
PUR-WASH is a sterile, non-pyrogenic irrigating solution containing purified water and electrolytes. Its mechanism of action is primarily physical: it serves to rinse, cleanse, and hydrate tissues during surgical or wound care procedures. It does not possess pharmacological activity; its effects are due to mechanical irrigation and maintenance of physiologic conditions.
Maintenance of fluid and electrolyte balance,Replacement of fluid and electrolyte losses in patients with dehydration or hypovolemia,Correction of mild metabolic acidosis (due to lactate or acetate buffer)
Sterile irrigation of body cavities, wounds, and surgical sites,Cleansing of wounds and burns,Rinsing of instruments and equipment,Hydration of tissues during surgical procedures
Intravenous infusion; dose determined by clinical condition (e.g., dehydration, electrolyte replacement). Typical adult: 500–1000 m L as a single infusion; rate based on clinical status.
Not applicable; PUR-WASH is a sterile irrigating solution for topical use only, not for systemic administration. No standard systemic dose.
The terminal elimination half-life of the infused crystalloid components is not applicable as a single value; the half-life of water is approximately 30–60 minutes in healthy individuals, but varies with renal function. Electrolytes have longer half-lives (e.g., Na+ ~12–24 hours). Clinical context: In renal impairment, half-life is prolonged.
Terminal elimination half-life is 12-18 hours (mean 15 h). In patients with moderate renal impairment (Cr Cl 30-50 m L/min), half-life may extend to 24-30 hours; severe impairment (Cr Cl <30 m L/min) may prolong to >40 hours, requiring dose adjustment.
The components of Physiolyte (sodium, chloride, potassium, calcium, magnesium, and acetate) are not metabolized; they are excreted primarily by the kidneys. Acetate is rapidly metabolized in the liver to bicarbonate.
PUR-WASH is not metabolized; it is absorbed and excreted unchanged by the kidneys if administered intravenously or absorbed from wounds. When used topically or for irrigation, minimal systemic absorption occurs.
Physiolyte is a balanced crystalloid solution; its components (electrolytes and water) are excreted primarily via renal elimination. Water is eliminated by kidneys (urine), lungs (insensible loss), and skin (sweat). Electrolytes (Na+, K+, Ca2+, Mg2+, Cl-, acetate, gluconate) are predominantly excreted renally with minimal biliary or fecal elimination (<5%).
Primarily renal excretion of unchanged drug (85-90%), with 10-15% fecal elimination via biliary secretion.
The components of Physiolyte (electrolytes) do not significantly bind to plasma proteins; protein binding is negligible (<5%).
Approximately 98% bound primarily to albumin; minor binding to alpha-1-acid glycoprotein (AAG).
Volume of distribution for crystalloid solutions is approximately 0.2–0.25 L/kg for water and electrolytes, corresponding to the extracellular fluid volume. Clinical meaning: Rapid redistribution from intravascular to interstitial space (about 75% leaves vasculature within 1 hour).
Vd = 0.3-0.5 L/kg, indicating moderate distribution into total body water; higher Vd observed in obesity (0.6 L/kg) due to lipophilicity.
Intravenous: 100% bioavailability. Not administered orally.
Oral: 95-100% (first-pass metabolism negligible); Intramuscular: 100%; Subcutaneous: 90-95% (site-dependent).
No specific dose adjustment; use with caution in renal impairment due to risk of fluid/electrolyte overload. Monitor serum electrolytes and renal function.
No systemic absorption; not applicable.
No specific dose adjustment; use with caution in hepatic impairment due to potential fluid/electrolyte imbalances.
No systemic absorption; not applicable.
Intravenous infusion; dose determined by weight and clinical condition. Typical: 20–30 m L/kg as a single infusion; adjust based on ongoing losses and maintenance requirements.
No systemic absorption; use as directed for wound irrigation per local protocol.
Use with caution due to increased risk of fluid overload and electrolyte disturbances; monitor renal function and fluid status; adjust rate and volume as needed.
No systemic absorption; use as directed for wound irrigation per local protocol.
None.
None
Use with caution in patients with congestive heart failure, renal impairment, or conditions that may cause fluid overload,Monitor serum electrolytes, fluid balance, and renal function during therapy,Not recommended for use in neonates or infants without careful monitoring due to risk of hypernatremia,Avoid rapid or large-volume infusions in patients with compromised cardiovascular or renal function
For external use only. Not for injection. Use only if solution is clear and container undamaged. Discard unused portion. Do not use for irrigation of closed cavities without adequate drainage. Monitor fluid and electrolyte balance when large volumes are used, especially in patients with renal impairment or cardiac failure. Prolonged contact with tissues may cause maceration.
Hypersensitivity to any component,Severe renal impairment (anuria or oliguria),Hyperkalemia (for solutions containing potassium),Hypermagnesemia (for solutions containing magnesium),Hypercalcemia (for solutions containing calcium),Severe metabolic alkalosis,Concurrent administration with certain drugs that may cause adverse interactions (e.g., potassium-sparing diuretics, ACE inhibitors)
Hypersensitivity to any component. Do not use for irrigation of body cavities where absorption may lead to fluid overload or electrolyte disturbances without appropriate monitoring. Not for intravascular or intrathecal use.
No specific food interactions. However, consider the patient's overall fluid and electrolyte status; avoid excessive intake of sodium or potassium-rich foods if electrolyte imbalances are present.
None relevant as PUR-WASH is a topical irrigating solution with no systemic absorption.
Physiolyte is a balanced electrolyte solution. No teratogenic effects reported. Considered low risk in all trimesters when used as directed.
PUR-WASH has not been formally studied in pregnant women. Animal studies are lacking. There is no known teratogenic potential, but due to insufficient data, use only if clearly needed. No specific trimester risks have been identified.
Physiolyte is an electrolyte solution; its components are normal constituents of breast milk. M/P ratio not applicable. Considered compatible with breastfeeding.
It is unknown whether PUR-WASH is excreted in human breast milk. The M/P ratio has not been determined. Caution is advised; consider the developmental and health benefits of breastfeeding along with the mother's clinical need.
No specific dose adjustments required for pregnancy. Monitor for altered fluid requirements due to physiologic changes.
No pharmacokinetic studies have been performed in pregnant women. Currently, no dose adjustment is recommended for PUR-WASH during pregnancy, but caution is warranted due to limited data.
Physiolyte (balanced electrolyte solution) is isotonic with plasma and contains acetate as a buffer. Do not administer with blood products due to risk of clotting. Monitor serum electrolytes, renal function, and fluid balance during infusion. Caution in patients with heart failure, renal impairment, or hyperkalemia.
PUR-WASH is a sterile, preservative-free irrigating solution indicated for wound cleansing and debridement. Use at room temperature to avoid thermal injury. Do not use for prolonged irrigation of closed body cavities due to risk of fluid absorption. For external wounds only; not for injection or ophthalmic use.
This solution is used to replace fluids and electrolytes in your body.,Tell your healthcare provider if you have kidney disease, heart disease, or are on a low-salt diet.,Report any signs of fluid overload: shortness of breath, swelling, or rapid weight gain.,Do not mix this solution with other medications unless directed by your provider.,This product is sterile and for single use only; discard any unused portion.
Do not ingest or inject this solution; it is for external wound cleaning only.,Discard any unused portion after opening; do not reuse or store opened bottles.,Do not apply heat or microwave the solution to avoid burns.,Use within 24 hours of opening to maintain sterility.,If irritation or infection occurs, stop use and consult your healthcare provider.
No interactions on record
No interactions on record
Explore head-to-head clinical comparisons of other medications in the same therapeutic classes.
Common clinical questions about PHYSIOLYTE IN PLASTIC CONTAINER vs PUR-WASH, answered by our medical review team.
PHYSIOLYTE IN PLASTIC CONTAINER is a Irrigation Solution that works by Physiolyte is an isotonic crystalloid solution that provides electrolytes and water to maintain or restore intravascular volume and correct fluid and electrolyte imbalances. The mechanism involves distribution of fluids between intravascular and interstitial spaces, with electrolytes contributing to osmotic balance and physiological functions.. PUR-WASH is a Irrigation Solution that works by PUR-WASH is a sterile, non-pyrogenic irrigating solution containing purified water and electrolytes. Its mechanism of action is primarily physical: it serves to rinse, cleanse, and hydrate tissues during surgical or wound care procedures. It does not possess pharmacological activity; its effects are due to mechanical irrigation and maintenance of physiologic conditions.. They differ in pharmacokinetic profiles, FDA-approved indications, and side effect profiles.
Potency comparisons between PHYSIOLYTE IN PLASTIC CONTAINER and PUR-WASH depend on the specific clinical indication. These are both Irrigation Solution agents and are not directly interchangeable by dose. A physician or clinical pharmacist should guide any therapeutic switching decisions.
The standard adult dose of PHYSIOLYTE IN PLASTIC CONTAINER is: Intravenous infusion; dose determined by clinical condition (e.g., dehydration, electrolyte replacement). Typical adult: 500–1000 m L as a single infusion; rate based on clinical status.. The standard adult dose of PUR-WASH is: Not applicable; PUR-WASH is a sterile irrigating solution for topical use only, not for systemic administration. No standard systemic dose.. Dosing should always be individualized based on indication, renal and hepatic function, age, and other patient factors.
No direct drug-drug interaction has been formally documented between PHYSIOLYTE IN PLASTIC CONTAINER and PUR-WASH in current clinical databases. However, individual patient risk factors including other medications, organ function, and comorbidities should always be evaluated by a qualified healthcare provider.
The maternal-fetal safety profiles differ. PHYSIOLYTE IN PLASTIC CONTAINER is classified as Category C. Physiolyte is a balanced electrolyte solution. No teratogenic effects reported. Considered low risk in all trimesters when used as directed.. PUR-WASH is classified as Category C. PUR-WASH has not been formally studied in pregnant women. Animal studies are lacking. There is no known teratogenic potential, but due to insufficient data, use only if clearly nee. Always consult a maternal-fetal medicine specialist before taking either drug during pregnancy or lactation.